50 related articles for article (PubMed ID: 34128720)
1. Comparison of Human Tissue Gadolinium Retention and Elimination between Gadoteridol and Gadobenate.
Kobayashi M; Levendovszky SR; Hippe DS; Hasegawa M; Murata N; Murata K; Marshall DA; Gonzalez-Cuyar LF; Maravilla KR
Radiology; 2021 Sep; 300(3):559-569. PubMed ID: 34128720
[TBL] [Abstract][Full Text] [Related]
2. Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats.
Robert P; Violas X; Grand S; Lehericy S; Idée JM; Ballet S; Corot C
Invest Radiol; 2016 Feb; 51(2):73-82. PubMed ID: 26606549
[TBL] [Abstract][Full Text] [Related]
3. Distribution and clearance of retained gadolinium in the brain: differences between linear and macrocyclic gadolinium based contrast agents in a mouse model.
Kartamihardja AA; Nakajima T; Kameo S; Koyama H; Tsushima Y
Br J Radiol; 2016 Oct; 89(1066):20160509. PubMed ID: 27459250
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium Chelate Contrast Material in Pregnancy: Fetal Biodistribution in the Nonhuman Primate.
Oh KY; Roberts VH; Schabel MC; Grove KL; Woods M; Frias AE
Radiology; 2015 Jul; 276(1):110-8. PubMed ID: 25763829
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium-based contrast agents aggravate mechanical and thermal hyperalgesia in a nitroglycerine-induced migraine model in male mice.
Bilgin B; Adam M; Hekim MG; Bulut F; Ozcan M
Magn Reson Imaging; 2024 Sep; 111():67-73. PubMed ID: 38604348
[TBL] [Abstract][Full Text] [Related]
6. Editorial for "Does the Higher Relaxivity of Gadobenate Dimeglumine Permit Gadolinium Dose-Lowering in MRI of the Central Nervous System? Results of a Retrospective, Parallel Group Comparison".
Kanal E
J Magn Reson Imaging; 2021 Nov; 54(5):1676-1677. PubMed ID: 34085348
[No Abstract] [Full Text] [Related]
7. Contrast Media-driven Anthropogenic Gadolinium: Knowns and Unknowns.
Lenkinski RE; Rofsky NM
Radiology; 2024 Apr; 311(1):e240020. PubMed ID: 38652027
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium Retention in Human Brain, Bone, and Skin.
Tweedle MF
Radiology; 2021 Sep; 300(3):570-571. PubMed ID: 34128728
[No Abstract] [Full Text] [Related]
9. Neurologic Effects of Gadolinium Retention in the Brain after Gadolinium-based Contrast Agent Administration.
Ayers-Ringler J; McDonald JS; Connors MA; Fisher CR; Han S; Jakaitis DR; Scherer B; Tutor G; Wininger KM; Dai D; Choi DS; Salisbury JL; Jannetto PJ; Bornhorst JA; Kadirvel R; Kallmes DF; McDonald RJ
Radiology; 2022 Mar; 302(3):676-683. PubMed ID: 34931861
[TBL] [Abstract][Full Text] [Related]
10. Clinical Efficacy of Reduced-Dose Gadobutrol Versus Standard-Dose Gadoterate for Contrast-Enhanced MRI of the CNS: An International Multicenter Prospective Crossover Trial (LEADER-75).
Liu BP; Rosenberg M; Saverio P; Weon YC; Peters S; Ardellier FD; Boeckenhoff A; Endrikat J
AJR Am J Roentgenol; 2021 Nov; 217(5):1195-1205. PubMed ID: 34133205
[No Abstract] [Full Text] [Related]
11. High-resolution vessel wall imaging for quantitatively and qualitatively evaluating in-stent stenosis of intracranial aneurysms.
Chen T; Liu S; Jiang Y; Wu W; Li J; Li K; Guo D
Front Neurol; 2024; 15():1381438. PubMed ID: 38784915
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium deposition in the liver and brain in a rat model with liver fibrosis after intravenous administration of gadoxetate disodium.
Wei P; Hu Q; He C; Hua P; Yang D; Shao C; Xie L; Han Z; Zhou X; Ding Z; Hu H
Heliyon; 2024 Mar; 10(6):e27419. PubMed ID: 38545226
[TBL] [Abstract][Full Text] [Related]
13. Gadolinium-based Contrast Agent Biodistribution and Speciation in Rats.
Le Fur M; Moon BF; Zhou IY; Zygmont S; Boice A; Rotile NJ; Ay I; Pantazopoulos P; Feldman AS; Rosales IA; How IDAL; Izquierdo-Garcia D; Hariri LP; Astashkin AV; Jackson BP; Caravan P
Radiology; 2023 Oct; 309(1):e230984. PubMed ID: 37874235
[TBL] [Abstract][Full Text] [Related]
14. Ten years of gadolinium retention and deposition: ESMRMB-GREC looks backward and forward.
van der Molen AJ; Quattrocchi CC; Mallio CA; Dekkers IA;
Eur Radiol; 2024 Jan; 34(1):600-611. PubMed ID: 37804341
[TBL] [Abstract][Full Text] [Related]
15. Prospective T1 mapping to assess gadolinium retention in brain after intrathecal gadobutrol.
Ringstad G; Valnes LM; Vatnehol SAS; Pripp AH; Eide PK
Neuroradiology; 2023 Sep; 65(9):1321-1331. PubMed ID: 37479768
[TBL] [Abstract][Full Text] [Related]
16. Prospective Safety Study of Intrathecal Gadobutrol in Different Doses.
Sperre A; Karsrud I; Rodum AHS; Lashkarivand A; Valnes LM; Ringstad G; Eide PK
AJNR Am J Neuroradiol; 2023 May; 44(5):511-516. PubMed ID: 37024308
[TBL] [Abstract][Full Text] [Related]
17. Validation of the simplified magnetic resonance index of activity by using DWI without gadolinium enhancement to evaluate bowel inflammation in Crohn's disease.
Bae H; Seo N; Kang EA; Cheon JH; Lim JS; Kim MJ
Eur Radiol; 2023 May; 33(5):3266-3275. PubMed ID: 36899087
[TBL] [Abstract][Full Text] [Related]
18. Analytical strategies to measure gadolinium as a wastewater marker in surface and groundwater systems.
Marazuela MÁ; Stockhausen M; Hofmann T
MethodsX; 2023; 10():101965. PubMed ID: 36578291
[TBL] [Abstract][Full Text] [Related]
19. Pseudocontinuous Arterial Spin Labeling: Clinical Applications and Usefulness in Head and Neck Entities.
Tanaka F; Umino M; Maeda M; Nakayama R; Inoue K; Kogue R; Obara M; Sakuma H
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010866
[TBL] [Abstract][Full Text] [Related]
20. Safety of gadolinium based contrast agents in magnetic resonance imaging-guided radiotherapy - An investigation of chelate stability using relaxometry.
Mahmood F; Nielsen UG; Jørgensen CB; Brink C; Thomsen HS; Hansen RH
Phys Imaging Radiat Oncol; 2022 Jan; 21():96-100. PubMed ID: 35243039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
